These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12959442)

  • 21. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive metabolic reprogramming in Group 3 medulloblastomas.
    Kp M; Kumar A; Biswas D; Moiyadi A; Shetty P; Gupta T; Epari S; Shirsat N; Srivastava S
    Brain Tumor Pathol; 2021 Apr; 38(2):96-108. PubMed ID: 33438046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clustering of self-organizing map identifies five distinct medulloblastoma subgroups.
    Cao C; Wang W; Jiang P
    Cancer Biomark; 2016; 16(3):327-32. PubMed ID: 26889815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8.
    De Bortoli M; Castellino RC; Lu XY; Deyo J; Sturla LM; Adesina AM; Perlaky L; Pomeroy SL; Lau CC; Man TK; Rao PH; Kim JY
    BMC Cancer; 2006 Sep; 6():223. PubMed ID: 16968546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive analysis of a microRNA expression profile in pediatric medulloblastoma.
    Dai J; Li Q; Bing Z; Zhang Y; Niu L; Yin H; Yuan G; Pan Y
    Mol Med Rep; 2017 Jun; 15(6):4109-4115. PubMed ID: 28440450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular array analyses of 51 pediatric tumors shows overlap between malignant intracranial ectomesenchymoma and MPNST but not medulloblastoma or atypical teratoid rhabdoid tumor.
    Kleinschmidt-DeMasters BK; Lovell MA; Donson AM; Wilkinson CC; Madden JR; Addo-Yobo SO; Lillehei KO; Foreman NK
    Acta Neuropathol; 2007 Jun; 113(6):695-703. PubMed ID: 17431644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
    Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
    Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
    Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
    Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.
    Neben K; Korshunov A; Benner A; Wrobel G; Hahn M; Kokocinski F; Golanov A; Joos S; Lichter P
    Cancer Res; 2004 May; 64(9):3103-11. PubMed ID: 15126347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioinformatics Analysis of Key Genes and Pathways for Medulloblastoma as a Therapeutic Target.
    Shaabanpour Aghamaleki F; Mollashahi B; Aghamohammadi N; Rostami N; Mazloumi Z; Mirzaei H; Moradi A; Sheikhpour M; Movafagh A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):221-227. PubMed ID: 30678435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid.
    Di C; Liao S; Adamson DC; Parrett TJ; Broderick DK; Shi Q; Lengauer C; Cummins JM; Velculescu VE; Fults DW; McLendon RE; Bigner DD; Yan H
    Cancer Res; 2005 Feb; 65(3):919-24. PubMed ID: 15705891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway.
    Gokhale A; Kunder R; Goel A; Sarin R; Moiyadi A; Shenoy A; Mamidipally C; Noronha S; Kannan S; Shirsat NV
    J Cancer Res Ther; 2010; 6(4):521-9. PubMed ID: 21358093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cell surface targets through meta-analysis of microarray data.
    Haeberle H; Dudley JT; Liu JT; Butte AJ; Contag CH
    Neoplasia; 2012 Jul; 14(7):666-9. PubMed ID: 22904683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components.
    Ehrbrecht A; Müller U; Wolter M; Hoischen A; Koch A; Radlwimmer B; Actor B; Mincheva A; Pietsch T; Lichter P; Reifenberger G; Weber RG
    J Pathol; 2006 Mar; 208(4):554-63. PubMed ID: 16400626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis.
    Li YX; Yu ZW; Jiang T; Shao LW; Liu Y; Li N; Wu YF; Zheng C; Wu XY; Zhang M; Zheng DF; Qi XL; Ding M; Zhang J; Chang Q
    Cancer Sci; 2018 Apr; 109(4):1263-1275. PubMed ID: 29369502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression and cellular distribution of gamma-tubulin and betaIII-tubulin in medulloblastomas and human medulloblastoma cell lines.
    Caracciolo V; D'Agostino L; Dráberová E; Sládková V; Crozier-Fitzgerald C; Agamanolis DP; de Chadarévian JP; Legido A; Giordano A; Dráber P; Katsetos CD
    J Cell Physiol; 2010 May; 223(2):519-29. PubMed ID: 20162618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes.
    Li Z; Wei Y; Shao Y; Tang L; Gong J
    Brain Tumor Pathol; 2021 Jul; 38(3):234-242. PubMed ID: 34180021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
    Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
    J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-34a deficiency accelerates medulloblastoma formation in vivo.
    Thor T; Künkele A; Pajtler KW; Wefers AK; Stephan H; Mestdagh P; Heukamp L; Hartmann W; Vandesompele J; Sadowski N; Becker L; Garrett L; Hölter SM; Horsch M; Calzada-Wack J; Klein-Rodewald T; Racz I; Zimmer A; Beckers J; Neff F; Klopstock T; De Antonellis P; Zollo M; Wurst W; Fuchs H; Gailus-Durner V; Schüller U; de Angelis MH; Eggert A; Schramm A; Schulte JH
    Int J Cancer; 2015 May; 136(10):2293-303. PubMed ID: 25348795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.